Kenneth Green, PhDExecutive Director MS&T at VertexSpeaker
Profile
Currently responsible for MSAT at Vertex for Cell & Gene Therapy within Commercial Manufacturing and Supply Chain. Previously held leadership roles managing DS Operations and MSAT functions at Samsung Biologics, S Korea. Ken has prior experience in process development & characterization, technology transfer, validation and production including leadership roles in Process Development and Technical Services with Lonza, GSK, Amgen, Pfizer and Shire. Ken has a passion for continuous improvement with application of six and lean sigma methodologies for efficiency gains, problem solving and strategy deployment. Graduated with degree in Microbiology from University of Sheffield, UK, followed by MSc and PhD degrees in Biochemical Engineering from University of Birmingham, UK.
Agenda Sessions
Building the Capabilities for Success in Cell Therapy Commercialization
, 11:30amView Session